These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9660997)

  • 1. In vitro and in vivo activities of levofloxacin against biofilm-producing Pseudomonas aeruginosa.
    Ishida H; Ishida Y; Kurosaka Y; Otani T; Sato K; Kobayashi H
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1641-5. PubMed ID: 9660997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levofloxacin penetrates human monocytes and enhances intracellular killing of Staphylococcus aureus and Pseudomonas aeruginosa.
    Smith RP; Baltch AL; Franke MA; Michelsen PB; Bopp LH
    J Antimicrob Chemother; 2000 Apr; 45(4):483-8. PubMed ID: 10747825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro synergy testing of levofloxacin, ofloxacin, and ciprofloxacin in combination with aztreonam, ceftazidime, or piperacillin against Pseudomonas aeruginosa.
    Pendland SL; Messick CR; Jung R
    Diagn Microbiol Infect Dis; 2002 Jan; 42(1):75-8. PubMed ID: 11821176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is levofloxacin as active as ciprofloxacin against Pseudomonas aeruginosa?
    Bonfiglio G
    Chemotherapy; 2001; 47(4):239-42. PubMed ID: 11399859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro efficacy of levofloxacin alone or in combination tested against multi-resistant Pseudomonas aeruginosa strains.
    Flynn CM; Johnson DM; Jones RN
    J Chemother; 1996 Dec; 8(6):411-5. PubMed ID: 8981179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levofloxacin, a broad spectrum anti-infective: from Streptococcus pneumoniae to Pseudomonas aeruginosa.
    Schito AM; Schito GC
    J Chemother; 2004 Apr; 16 Suppl 2():3-7. PubMed ID: 15255554
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experimental pneumonia with Pseudomonas aeruginosa in immunosuppressed guinea pigs as a model for biofilm-associated infection].
    Ishida Y
    Kansenshogaku Zasshi; 1995 May; 69(5):572-81. PubMed ID: 7602191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo oral efficacy of levofloxacin for treatment of systemic Pseudomonas aeruginosa infections in a murine model of septicemia.
    Yagel SK; Barrett JF; Amaratunga DJ; Frosco MB
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2894-7. PubMed ID: 9124863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bactericidal activity of various antibiotics against biofilm-producing Pseudomonas aeruginosa.
    Abdi-Ali A; Mohammadi-Mehr M; Agha Alaei Y
    Int J Antimicrob Agents; 2006 Mar; 27(3):196-200. PubMed ID: 16459057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bactericidal activity of levofloxacin and ciprofloxacin on clinical isolates of different phenotypes of Pseudomonas aeruginosa.
    Segatore B; Setacci D; Perilli M; Franceschini N; Marchetti F; Amicosante G
    Int J Antimicrob Agents; 2000 Jan; 13(3):223-6. PubMed ID: 10724029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the bactericidal activities of ofloxacin and ciprofloxacin alone and in combination with ceftazidime and piperacillin against clinical strains of Pseudomonas aeruginosa.
    Klepser ME; Patel KB; Nicolau DP; Quintiliani R; Nightingale CH
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2503-10. PubMed ID: 8585734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo activity of EDTA and antibacterial agents against the biofilm of mucoid Pseudomonas aeruginosa.
    Liu Z; Lin Y; Lu Q; Li F; Yu J; Wang Z; He Y; Song C
    Infection; 2017 Feb; 45(1):23-31. PubMed ID: 27189338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of activities of levofloxacin, alone and combined with gentamicin, ceftazidime, cefpirome, and meropenem, against 124 strains of Pseudomonas aeruginosa by checkerboard and time-kill methodology.
    Visalli MA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1998 Apr; 42(4):953-5. PubMed ID: 9559819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and pharmacodynamics of gemifloxacin versus levofloxacin in guinea pig pneumococcal pneumonia induced by strains with decreased ciprofloxacin susceptibility.
    García-Olmos M; Parra A; García-Calvo G; Ponte C; Giménez MJ; Aguilar L; Soriano F
    Int J Antimicrob Agents; 2003 Jun; 21(6):568-73. PubMed ID: 12791471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Italian survey on comparative levofloxacin susceptibility in 334 clinical isolates of Pseudomonas aeruginosa.
    Segatore B; Setacci D; Perilli M; Franceschini N; De Santis A; Marchetti F; Amicosante G
    Antimicrob Agents Chemother; 1999 Feb; 43(2):428-31. PubMed ID: 9925553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ofloxacin, norfloxacin and ceftazidime increase the production of alginate and promote the formation of biofilm of Pseudomonas aeruginosa in vitro.
    Takahashi A; Yomoda S; Ushijima Y; Kobayashi I; Inoue M
    J Antimicrob Chemother; 1995 Oct; 36(4):743-5. PubMed ID: 8591955
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro prevention of Pseudomonas aeruginosa early biofilm formation with antibiotics used in cystic fibrosis patients.
    Fernández-Olmos A; García-Castillo M; Maiz L; Lamas A; Baquero F; Cantón R
    Int J Antimicrob Agents; 2012 Aug; 40(2):173-6. PubMed ID: 22727530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antibacterial efficacy of levofloxacin and ciprofloxacin against Pseudomonas aeruginosa assessed by combining antibiotic exposure and bacterial susceptibility.
    MacGowan AP; Wootton M; Holt HA
    J Antimicrob Chemother; 1999 Mar; 43(3):345-9. PubMed ID: 10223589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of 4-quinolones against Pseudomonas aeruginosa.
    Morissey I; Smith JT
    Arzneimittelforschung; 1994 Oct; 44(10):1157-61. PubMed ID: 7818593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effect of oral levofloxacin, ciprofloxacin, and ampicillin on experimental murine pneumonia caused by penicillin intermediate Streptococcus pneumoniae for which the minimum inhibitory concentrations of the quinolones are similar.
    Ishida Y; Kurosaka Y; Murakami Y; Otani T; Yamaguchi K
    Chemotherapy; 1999; 45(3):183-91. PubMed ID: 10224340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.